MedTrace Logo

Mild Traumatic Brain Injury and the Risk for Traumatic Intracranial Hemorrhage

NCT05609721 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2044

Last updated 2022-11-08

No results posted yet for this study

Summary

Management of traumatic brain injuries causes significant efforts on emergency departments (ED) and overall health care. Patients on antithrombotic treatment with even minor trauma to the head, although without significant clinical findings, represent special challenges because the risk of traumatic intracranial hemorrhage (tICH) with these agents. The aim of this study was to compare the prevalence of tICH in patients on various pre-injury antithrombotic treatment exposed to minor Traumatic Brain injuries (mTBI) in Sundsvall with untreated patients. Secondary aim was to explore different risk factors for tICH.

Data from medical records and radiology registry with mTBI in Sundsvall hospital between 2018-2020 in Sundsvall identified 2044 patients. Demographic data, pre-injury medications with antithrombotic treatment, state of consciousness at admission and the results of CT-scans of brain was investigated.

Conditions

  • Traumatic Intracranial Hemorrhage
  • Brain Injuries

Interventions

OTHER

no intervention, only observational study

no intervention, only observational study

Sponsors & Collaborators

  • Umeå University

    lead OTHER

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-03-30
Completion
2021-06-20

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05609721 on ClinicalTrials.gov